KRAS G12c Mutant
Cancers carrying the KRAS G12C mutation — the first KRAS variant with approved targeted drugs.
If KRAS G12c Mutant is on your watch list: what changed in the coverage, our read on what happens next vs. the crowd, and what to watch.
Cancers carrying the KRAS G12C mutation — the first KRAS variant with approved targeted drugs.
If KRAS G12c Mutant is on your watch list: what changed in the coverage, our read on what happens next vs. the crowd, and what to watch.